Important Outcome for Children with ALL BRIDGEWATER, N.J. -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced it entered into an agreement with Ovation Pharmaceuticals, Inc. for the supply of the active ingredient used in the production of Enzon's Oncaspar...

PISCATAWAY, N.J.--(BUSINESS WIRE)--May 13, 1998--Enzon, Inc. (NASDAQ:ENZN) announced today that its marketing partner, Rhone-Poulenc Rorer Pharmaceuticals, Inc. (RPR RPR - Minor Repairs (book condition)RPR - Raipur, India (Airport Code)RPR - Rapid Plasma ReaginRPR - ...

PISCATAWAY, NJ--Nov. 17, 1994--(BUSINESS WIRE)--Enzon, Inc. (NASDAQNMS:ENZN) announced today that the German Federal Institute for Phamaceuticals and Medical Products (BGA) has granted marketing approval for ONCASPAR (pegaspargase pegaspargase /peg·as·parÂ...

BRIDGEWATER, N.J. -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) announced today that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License Application (sBLA) for its oncology product, Oncaspar (pegaspargase pegaspargase...

Business Editors, Health/Medical Writers Enzon, Inc. (NASDAQ:ENZN) announced today that it has entered into an agreement with Aventis (NYSE:AVE) that provides for Enzon to reacquire its rights to market and distribute its product ONCASPAR(R) (pegaspargase pegasparga...

BRIDGEWATER, N.J. -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced its financial results for the quarter ended September 30, 2005, the first quarter of Enzon's six-month transition period ending on December 31, 2005. In January 2005, Enzon announced a ...

PISCATAWAY, NJ--(BUSINESS WIRE)--Jan. 11, 1995--(NASDAQ:NMSENZN) At an Annual Stockholders' Meeting held the evening of January 10, 1995, Peter G. Tombros, Enzon's President and CEO, provided stockholders with a review of the state of the business.In his address, M...

SANTA CLARA, Calif. and COLLEGEVILLE, Pa.--(BUSINESS WIRE)-- April 24, 1995--Applied Immune Sciences Inc. (AIS AIS - Abbreviated Injury Scale (accident analysis)AIS - ABCs Information ServicesAIS - Abu-Dhabi International School (Abu Dhabi, UAE)AIS - Academic Instruct...

Definition ...

In 1994, 62 new drugs were approved and 23 new biologics, including vaccines, were licensed by FDA. The median drug approval time was 19 months and for the biologics, 12.2 months--in both cases, a significant improvement over 1993. ...

TABLE 1 Causes of Night Sweats Malignancy Lymphoma Leukemia Other neoplasm Infections Human immunodeficiency virus Tuberculosis Mycobacterium avium complex Infectious mononucleosis Fungal infections (histoplasmosis, coccidioidomycosis) Lung absces...